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Whole exome sequencing (WES)Paramyotonia congenita (PC) is a rare autosomal dominant neuromuscular disorder characterized by juvenile
onset and development of cold-induced myotonia after repeated activities. The disease is mostly caused by ge-
netic mutations of the sodium channel, voltage-gated, type IV, alpha subunit (SCN4A) gene. This study intended
to systematically identify the causative genetic variations of a Chinese Han PC family. Seven members of this PC
family, including four patients and three healthy controls, were selected for whole exome sequencing (WES)
using the Illumina HiSeq platform. Sequence variations were identiﬁed using the SoftGenetics program. The
mutation R1448C of SCN4A was found to be the only causative mutation. This study applied WES technology
to sequence multiple members of a large PC family and was the ﬁrst to systematically conﬁrm that the genetic
change in SCN4A is the only causative variation in this PC family and the SCN4A mutation is sufﬁcient to lead
to PC.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Paramyotonia congenita (PC), ﬁrst described by von Eulenburg, is an
autosomal dominant disorder characterized by increased stiffness on
repeated activities and cold-induced skeletal muscle myotonia [1]. The
onset of PC usually begins early in life, with myotonic discharges as
the chief abnormal features of electromyographic recordings [1,2]. In
most known cases, PC is caused by a single nucleotide mutation in the
SCN4A gene that encodes the alpha-subunit of the skeletal muscle sodi-
um channel [3]. The SCN4A gene is located on chromosome 17q23–25
and consists of 24 exons with a 5.5-kb open reading frame [4,5]. The
SCN4A protein comprises 1836 amino acids and mediates the initiation
and propagation of action potentials in skeletalmuscle cells [4,5]. It con-
tains four homologous domains (DI, DII, DIII, and DIV) and each domain
possesses six transmembrane alpha-helical segments (S1, S2, S3, S4, S5
and S6), of which, the S4 segment is thought to be involved in voltage-
dependent gating of the skeletal muscle sodium channel, based on its
high concentrations (Fig. 1) [5].
With the development of whole exome sequencing (WES), it has
now become possible to take advantage of this powerful and cost-
effective new tool for analyzing the genetic basis of diseases and features
that have proved to be unyielding to conventional gene-discovery strat-
egies [6]. Consequently, the sequence of an individual's entire exome
and even genomewill quickly become available, enormously facilitating
clinical screening and diagnosis [7,8]. In this study, we applied WES to. This is an open access article underanalyze the genetic composition of a family, whose members were
affected by PC, and successfully identiﬁed the mutation R1448C of the
SCN4A gene. Since thedisease is very rare, ourﬁndingswill be a valuable
addition to the genetic and epidemiological data of PC in the Chinese
population.
Results
Preliminary analysis using NextGENe™ software
Considering that PC is transmitted in an autosomal dominant pat-
tern, we assumed that heterozygous mutations were the underlying
cause for the disease the patients were suffering. Through NextGENe™
software processing with the human genome GRCh37/hg19 as the ref-
erence, we obtained 2,077,720 to 2,458,338 single nucleotide variations
(SNV) and 345,175 to 453,177 InDels (short insertions or deletions)
from the four patients and three healthy family members (see details
in Table 1).
Further screening via bioinformatic methods and Sanger sequencing
With the removal of the describedmutations that were also present
in the healthy members, the shared SNVs and InDels were signiﬁcantly
reduced to 14 and 3, respectively. After ﬁltering the remainingmuta-
tions against the multiple databases, including the dbSNP, HapMap,
the 1000 Genome, and in-house exome data (from the Beijing Geno-
mics Institute, Shenzhen, China), the candidate variants werethe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Voltage-sensitive sodium channelα-subunit. The channel consists of four homologous domains (DI, DII, DIII, and DIV), each with six transmembrane α-helix segments (S1, S2, S3,
S4, S5, and S6). In each domain, the S4 segment (green block) is suggested to be involved in voltage-dependent gating of the skeletalmuscle sodium channel due to the high concentration
of positive charge in S4 segment. The high concentration of positive charge in this α-helical segment suggests that the S4 segment is involved in voltage-dependent gating (red plus
symbol).
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removed via bioinformatics methods, mainly the SIFT software
(http://sift.jcvi.org) [9]. Afterwards, only 6 SNVs and 3 InDels were
left. Sanger DNA sequencing was performed with the remaining
family members and 5 mutations were also found in the additional
healthymembers. After sequencing conﬁrmation, 2 SNV and 2 InDels
remained to be associated with all the patients (Table 2). As expect-
ed, the SCN4A mutation existed in the screened list. The missense
mutation (the c.4342GNA [p.Arg1448Cys]) identiﬁed in this family
was previously reported as the causative variant for PC [10].
Discussion
In our current study, we performed a systematicWES to identify the
causative variant leading to PC in a large PC family in China. We found
mutations and InDels in four genes associated with PC after sequencing
and mutational analysis. To further narrow the gene list, we performed
an additional reference search. The gene adenylate cyclase 10 (ADCY10)
encoding the soluble adenylyl cyclase plays a critical role inmammalian
spermatogenesis [11]. Genetic variations in this gene have been reported
to be associated with absorptive hypercalciuria [12]. Research has also
shown that variations in ADCY10 may have a modest effect on peak spi-
nal bone mineral density (BMD) in healthy women [13]. Mouse Genome
Informatics (MGI) has described a knock-out type ADCY10tm1Lex that
replaced exons 2, 3 and 4. Without the main structure of the catalytic
domain, the knock-outmouse exhibited a variety of infertility symptoms.
As a consequence, mutation c.1162TNC (p.388SNGS) of ADCY10 was un-
likely to be the causative gene of the patients' disorder. The neuromedin
U (NMU) gene encodes Neuromedin U that stimulates muscle contrac-
tion of speciﬁc regions of the gastrointestinal tract. In humans, NMU
stimulates the contraction of the ileum and urinary bladder [14]. Abnor-
malities of this gene almost invariably lead to overweight and obesity
[15]. With the insertion of c.86_87insAGC, which causes the frameshift,
NMU will lose the active catalytic domain. MGI has been shown to
produce a knock-out type NMUtm1Mko with PGK-Neo replacing exon 9
(the active C-terminal portion of NMU) via homologous recombination.
Obesity represents one of the signiﬁcant symptoms of the knock-outTable 1
Summary of the mutation data from seven members of the PC family.
Sample ID Mismatches count. InDels count.
Patient I-2 2135048 388705
Patient II-1 2148577 348610
Patient II-9 2185421 345175
Patient III-1 2200776 404206
Healthy member III-3 2457514 453177
Healthy member III-4 2077720 369044
Healthy member III-14 2458338 429397
InDels, short insertions and deletions.mice, which also include increased fat cell size, hypoactivity, impaired
adaptive thermogenesis and hepatic steatosis. In addition, a large number
of studies have demonstrated that mutations in the NMU gene is associ-
ated with cancer [16–18]. Therefore, the NMU gene may not have
contributed to PC of the patient family.
Gene proprotein convertase subtilisin/kexin type 4 (PCSK4) encodes
a member of the subtilisin-like proprotein convertase family and is
expressed only in the testis, placenta, and ovary. In rodents, deletion
of PCSK4 results in severely impaired fertility in the absence of any
evident spermatogenic abnormality [19]. Mutations identiﬁed in the
collected PC family may represent individual variation, instead of
disease association.
After elimination of the abovementioned genes, SCN4A remained as
the only possible pathogenic gene with connections to the disease.
Previous research has demonstrated that mutations of SCN4A were
the causative factors for paramyotonia congenita [5]. Based on the
results of our analysis, the variant c.4342GNA (p.1448RNRC) seems to
be partially or even solely responsible for the PC disease (Fig. 2A). The
mutation in SCN4A, whichwas further conﬁrmed by Sanger sequencing
(Fig. 2B), altered the 1448th codon CGA for arginine into TGA for cyste-
ine. Consequently, this missense mutation resulted in a change in
electric charge, which transformed the positive charge into neutral
[10]. The gene SCN4A encodes sodium channel, voltage-gated, type IV,
alpha subunit (Fig. 1), which plays a primary role in action potential
initiation and propagation in excitable cells, including nerve, muscle
and neuroendocrine cell types [20]. Structurally, the protein has four
homologous domains (DI, DII, DIII, and DIV), each of which consists of
six transmembrane alpha-helical segments (S1, S2, S3, S4, S5, and S6).
The S4 segment in each domain contains from four to seven repeated
three-residue motifs of a positively charged amino acid (usually argi-
nine) followed by two hydrophobic amino acids [21]. The high concen-
tration of positive charges in this alpha-helical segment suggests that
the S4 segment is involved in voltage-dependent gating [5].
WES has become increasingly popular and has already shown prom-
ise as a valuable diagnostic tool for patients with confusing phenotypes
and features suggesting a primary genetic etiology, such as a strong
family history, developmental anomalies, or uncustomary presentations
of common diseases [22,23]. Through this powerful technology, the PC
phenotype-causing variant of this family was identiﬁed as the R1448C
mutation of gene SCN4A. The R1448C mutation of SCN4A is commonly
considered as the causative factor. This variant is consistent with epide-
miological data from other countries [10,21,24]. According to previous
studies, themost representative features of myotoniamay be explained
by the abnormal hyperexcitability of skeletal muscle induced by altered
inactivation. Themutation R1448C of gene SCN4A slows down the inac-
tivation rate of the skeletal muscle sodium channel and invalidates
rapid recovery from inactivation [10]. As a result of the alterations
in channel kinetics, there is a prolonged inward (depolarizing) current
following muscle excitation, which may lead to myotonia.
Table 2
SNV and InDel associated with PC.
Gene Chr Gene Dir. Chromosome position RNA accession SNP db_xref Reference nucleotide Genotype Mutation call Amino acid change
ADCY10 1 – 167849407 NM_018417.4 T CT c.[1162TNC]+[=] 388SNGS
NMU 4 – 56502274 NM_006681.2 A insAGC c.86_87insAGC FS
SCN4A 17 – 62019300 NM_000334.4 rs121908544 G GA c.[4342GNA]+[=] 1448RNCR
PCSK4 19 – 1482365 NM_017573.3 C delCT c.1805_1806delCT FS
Chr, chromosome; Gene Dir, gene direction; SNP, single nucleotide polymorphism; del, deletion; ins, insertion; FS, frameshift.
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may help to make a contribution to build an epidemiological database
for paramyotonia congenita. Our work is the ﬁrst to systematically
conﬁrm that the genetic mutation in SCN4A is sufﬁcient to lead to PC.
Materials and methods
Pedigree of the PC patients family
The affected family (Fig. 3), which originated from the Southwestern
China pedigree (Chinese Han), had an onset in infancy. The proband
(II-9) beganwithmyotonia andweakness induced by cold temperatures
in distal limbmuscles and also showedptosis. All of thepatients exhibited
similar clinical manifestations, but did not present any severe symptoms,
such as amyotrophia and dyspnea.
Genomic DNA extraction from saliva of the PC patients
Genomic DNA was extracted from 2–5 ml saliva collected from the
family members. After collection, 5 ml of Nuclei-SDS-ProteinaseK-Fig. 2. R1448C mutation of gene SCN4A in NextGENe™ panel and conﬁrmed by Sanger seque
ﬁltering, R1448C mutation of the gene SCN4A had been suspected to be the causative mutatio
showing the CGTNTGTheterozygousmutation. Right is control III-14, and the sequence is consist
by Sanger sequencing in the proband (II-9) with heterozygous A/G. (C) Sanger sequencing of tMastermix lysis buffer (NaCl 1.44 mM, Proteinase K 0.14 mg/ml, SDS
0.024mM, EDTA 0.35 μM)was added immediately to the saliva sample.
After incubation at 50 °C overnight, 3 ml saturated NaCl solution was
added for salt precipitation, followed with ethanol precipitation. The
DNA pellet was washed twice with 70% ethanol and dissolved in
redistilled water.Sequencing platform and bioinformatics software
For WES, the DNA coding sequence was enriched with the
Agilent SureSelectXT Human All Exon kit. A sequencing library
was prepared using the Illumina next generation sequencing
kit. The Illumina HiSeq2000 sequencer (Illumina, San Diego, CA)
was used for sequencing. The reads produced by sequencing were
aligned for single nucleotide polymorphism (SNP) and InDel-calling
using the NextGENe™ (SoftGenetics LLC) software. Raw data from
the 7 samples (members with red asterisks in Fig. 3) were analyzed
in NextGENe™ according to the manufacturer's standard analysis
process.ncing. (A) WES results were analyzed by the NextGENe™ software. After alignment and
n. This ﬁgure showed the software panel of the R1448C mutation site. Left is Patient II-9,
entwith the reference. (B) Amissensemutation R1448C of the gene SCN4Awas conﬁrmed
he R1448C-containing region from control (III-14).
Fig. 3. Pedigree of the PC patients family. Males are represented by squares, females by circles, deceased by diagonals, and affected members by ﬁlled symbols. The proband (II-9) is
indicated by an arrow. Asterisks (*) indicate that available DNA samples were used for WES. For simplicity, spouses and children of normal siblings in generations III are not shown.
Also, only the affected individuals and individuals visited in this study are numbered in the pedigree tree.WES for II-3 has not been performed, but has completed subsequent genotyping
for ﬁltering.
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A SNP detection and InDel-calling algorithmwas run by high conﬁgu-
ration servers. Nonsynonymous/splice acceptor and donor site/insertions
or deletions in the dbSNP (http://www.ncbi.nlm.nih.gov/projects/SNP/),
HapMap samples, and 1000 Genome (http://www.ncbi.nlm.nih.gov/
Ftp/) with a frequency higher than 0.5% were removed. Synonymous
changes and non-coding changes were ﬁltered using the SIFT software
(http://sift.jcvi.org). Sanger sequencing with speciﬁc primers was used
to conﬁrm themutation fromall of the samples collected from the family.
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